These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Integrative mutation, haplotype and G × G interaction evidence connects ABGL4, LRP8 and PCSK9 genes to cardiometabolic risk. Guo T; Yin RX; Yao LM; Huang F; Pan L; Lin WX; Yang DZ; Pan SL Sci Rep; 2016 Nov; 6():37375. PubMed ID: 27853278 [TBL] [Abstract][Full Text] [Related]
30. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204 [TBL] [Abstract][Full Text] [Related]
31. PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway. Liu LS; Bai XQ; Gao Y; Wu Q; Ren Z; Li Q; Pan LH; He NY; Peng J; Tang ZH J Alzheimers Dis; 2017; 57(3):723-734. PubMed ID: 28304296 [TBL] [Abstract][Full Text] [Related]
32. Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations. Hayat M; Kerr R; Bentley AR; Rotimi CN; Raal FJ; Ramsay M PLoS One; 2020; 15(2):e0229098. PubMed ID: 32084179 [TBL] [Abstract][Full Text] [Related]
33. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events. Ridker PM; Rifai N; Bradwin G; Rose L Eur Heart J; 2016 Feb; 37(6):554-60. PubMed ID: 26508163 [TBL] [Abstract][Full Text] [Related]
34. VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly. Croyal M; Blanchard V; Ouguerram K; Chétiveaux M; Cabioch L; Moyon T; Billon-Crossouard S; Aguesse A; Bernardeau K; Le May C; Flet L; Lambert G; Hadjadj S; Cariou B; Krempf M; Nobécourt-Dupuy E Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):819-829. PubMed ID: 32078365 [TBL] [Abstract][Full Text] [Related]
35. Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression. Gong Y; Ma Y; Ye Z; Fu Z; Yang P; Gao B; Guo W; Hu D; Ye J; Ma S; Zhang F; Zhou L; Xu X; Li Z; Yang T; Zhou H Metabolism; 2017 Nov; 76():32-41. PubMed ID: 28987238 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive. Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253 [TBL] [Abstract][Full Text] [Related]